Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 17 Source: Company
- €742 million turnover
-
-€121 million
profit - 2,000 employees
-
31st Dec 16 Source: CRO
- €438 million turnover
-
€147.3 million
profit - 380 employees
- 5 more years available »
Ranking
By Turnover
(€742 million)- 106th in Top Companies
- 17th in Health
- 17th in Pharma
By Employees
(2,000)- 114th in Top Companies
- 18th in Health
- 7th in Pharma
-
- 2,000
- €742 million
Employees
- James Burke Director
Latest News
- 1:45pm State recovers €14.3bn from Apple over alleged State aid
- 1:45pm Revenue warns Airbnb hosts they are liable for tax
- 1:40pm Salary increases prompting more workers to change job - report
- 1:02pm Marsh & McLennan buys UK insurere Jardine Lloyd Thompson for £4.3bn
- 1:02pm Marsh & McLennan buys UK insurer Jardine Lloyd Thompson for £4.3bn